Abstract
Purpose
The main objective of the present study is to compare the safety, technical success and diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) versus ultrasound-guided percutaneous core-needle biopsy (US-CNB) in patients with solid pancreatic lesions.
Methods
This is a retrospective study that involved all patients with a solid pancreatic lesion who underwent EUS-FNA or US-CNB between November 2019 and February 2021. Of all patients, 69 (84.1%) had inoperable malignancy, whereas 13 (15.9%) had chronic pancreatitis. Resectability status was ascertained by computed tomography. All core needle biopsies were performed by the same interventional radiologist via ultrasound guidance with an 18-gauge semi-automatic tru-cut needle. All EUS-FNA procedures were performed by the same gastroenterologist with a 27-gauge EUS-FNA needle. Technical success is defined as if the region of interest is reached and specimen taken from the pancreatic lesion. Diagnostic yield is defined as the procurement of sufficient tissue for pathological examination.
Results
Overall, 52 patients (mean age 58.5 ± 9.8 years) who underwent EUS-FNA and 30 patients (60.1 ± 12.1 years) who underwent US-CNB were included. Solid lesions were most commonly (61.5% in EUS-FNA and 50.0% in US-CNB groups) located in pancreatic head in both groups. Mean size of the lesions was comparable in both groups as well. The technical success was 100% in both groups. In 12 (14.6%) patients, pathology results revealed inadequate sampling (11 × in the EUS-FNA and 1 × in the US-CNB group). The diagnostic yield was significantly higher in US-CNB group than in EUS-FNA group (96.7% vs. 78.8%, respectively, p = 0.048). Of 11 patients in the EUS-FNA with inadequate sampling, pancreatic lesions were located in the pancreatic head in 7 (63.6%). No major complications were observed in neither of the groups. As a minor complication, one case of slight abdominal pain was detected in the EUS-FNA group.
Conclusion
Based on the results of the present study, both US-CNB and EUS-FNA appeared safe; however, diagnostic yield in the US-CNB group was significantly higher.
Similar content being viewed by others
Data Availability
We added data of the present study with a link*. *https://figshare.com/projects/Diagnostic_Evaluation_of_Solid_Pancreatic_Lesions_Endoscopic_Ultrasound-Guided_Fine_Needle_Aspiration_versus_Ultrasound-Guided_Core_Needle_Biopsy/128942.
References
Ducreux M, Cuhna AS, Caramella C, Hollebecque A, Burtin P, Goere D, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v56-68.
Tokar JL, Walia R. Diagnostic evaluation of solid pancreatic masses. Curr Gastroenterol Rep. 2013;15(10):347.
Guarneri G, Gasparini G, Crippa S, Andreasi V, Falconi M. Diagnostic strategy with a solid pancreatic mass. Presse Med. 2019;48(3 Pt 2):e125–45.
Chen PT, Liu KL, Cheng TY, Chang CC, Chang YC. Indirect percutaneous core needle biopsy of solid pancreatic or peripancreatic lesions. Abdom Radiol (NY). 2019;44(1):292–303.
Huang Y, Shi J, Chen YY, Li K. Ultrasound-guided percutaneous core needle biopsy for the diagnosis of pancreatic disease. Ultrasound Med Biol. 2018;44(6):1145–54.
Bhatti I, Ojo D, Dennison AR, Rees Y, Elabassy M, Garcea G. Percutaneous pancreatic biopsies-still an effective method for histologic confirmation of malignancy. Surg Laparosc Endosc Percutan Tech. 2016;26(4):334–7.
Sur YK, Kim YC, Kim JK, Lee JH, Yoo BM, Kim YB. Comparison of ultrasound-guided core needle biopsy and endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesions. J Ultrasound Med. 2015;34(12):2163–9.
Schoellnast H, Komatz G, Bisail H, Talakic E, Fauster M, Ehammer T, et al. CT-guided biopsy of lesions of the lung, liver, pancreas or of enlarged lymph nodes: value of additional fine needle aspiration (FNA) to core needle biopsy (CNB) in an offsite pathologist setting. Acad Radiol. 2010;17(10):1275–81.
Micames C, Jowell PS, White R, Paulson E, Nelson R, Morse M, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc. 2003;58(5):690–5.
Tempero MA, Malafa MP, Al-Hawary M, Behrman SW, Benson AB, Cardin DB, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2021;19(4):439–57.
Kahriman G, Ozcan N, Dogan S, Ozmen S, Deniz K. Percutaneous ultrasound-guided core needle biopsy of solid pancreatic masses: Results in 250 patients. J Clin Ultrasound. 2016;44(8):470–3.
Yang RY, Ng D, Jaskolka JD, Rogalla P, Sreeharsha B. Evaluation of percutaneous ultrasound-guided biopsies of solid mass lesions of the pancreas: a center’s 10-year experience. Clin Imaging. 2015;39(1):62–5.
Mallery JS, Centeno BA, Hahn PF, Chang Y, Warshaw AL, Brugge WR. Pancreatic tissue sampling guided by EUS, CT/US, and surgery: a comparison of sensitivity and specificity. Gastrointest Endosc. 2002;56(2):218–24.
Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, et al. Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2017;15(8):1028–61.
Gupta S, Wallace MJ, Cardella JF, Kundu S, Miller DL, Rose SC, et al. Quality improvement guidelines for percutaneous needle biopsy. J Vasc Interv Radiol. 2010;21(7):969–75.
Kanno A, Ishida K, Hamada S, Fujishima F, Unno J, Kume K, et al. Diagnosis of autoimmune pancreatitis by EUS-FNA by using a 22-gauge needle based on the International Consensus Diagnostic Criteria. Gastrointest Endosc. 2012;76(3):594–602.
Bhatia V, Varadarajulu S. Endoscopic ultrasonography-guided tissue acquisition: how to achieve excellence. Dig Endosc. 2017;29(4):417–30.
Ecka RS, Sharma M. Rapid on-site evaluation of EUS-FNA by cytopathologist: an experience of a tertiary hospital. Diagn Cytopathol. 2013;41(12):1075–80.
Roy A, Kim M, Hawes R, Varadarajulu S. Changing trends in tissue acquisition in malignant pancreatic neoplasms. J Gastroenterol Hepatol. 2016;31(2):501–5.
Kanata R, Sasaki T, Matsuyama M, Ishigaki K, Yamada I, Ozaka M, et al. Prospective study of EUS-guided tissue acquisition with a 20G core biopsy needle with a forward bevel for solid pancreatic mass. Medicine (Baltimore). 2021;100(2):e24193.
Chen YI, Chatterjee A, Berger R, Kanber Y, Wyse JM, Lam E, et al. EUS-guided fine needle biopsy alone vs. EUS-guided fine needle aspiration with rapid on-site evaluation of cytopathology in pancreatic lesions: a multicenter randomized trial. Endoscopy. 2021;54:4–12.
Xin Y, Yang Y, Chen Y, Wang Y, Cao XJ, Zhou X. Safety and efficacy of ultrasound-guided percutaneous coaxial core biopsy of pancreatic lesions: a retrospective study. J Ultrasound. 2021;24(3):269–77.
Stella SF, Van Borsel M, Markose G, Nair SB. Image-guided percutaneous biopsy for pancreatic lesions: 10-year experience in a tertiary cancer center. Can Assoc Radiol J. 2019;70(2):199–203.
Wang KX, Ben QW, Jin ZD, Du YQ, Zou DW, Liao Z, et al. Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. Gastrointest Endosc. 2011;73(2):283–90.
Funding
O.A. was partially supported by the NIH/NCI Cancer Center Support Grant P30 CA008748.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Caymaz, I., Afandiyeva, N. Diagnostic Evaluation of Solid Pancreatic Lesions: Endoscopic Ultrasound-Guided Fine Needle Aspiration Versus Percutaneous Ultrasound-Guided Core Needle Biopsy. Cardiovasc Intervent Radiol 46, 1596–1602 (2023). https://doi.org/10.1007/s00270-023-03494-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-023-03494-y